Two pregnant patients received radiation therapy, one for the treatment of mediastinal Hodgkin's lymphoma and the other for a head and neck squamous cell carcinoma. The fetuses were both protected by additional shielding which reduced the unshielded exposure of the first fetus by 20-40%, and that of the second by 20-60%. The first child received an estimated maximum dose of 42 cGy, the second a maximum dose of 9 cGy. Treatment details are reported and a review of the literature that addresses the possible irradiation-induced side effects at low doses is included.

, ,
doi.org/10.1016/S1278-3218(02)00249-4, hdl.handle.net/1765/68871
Cancer/Radiotherapie
Department of Radiation Oncology

Nuyttens, J., Prado, F., Jenrette, J., & Williams, T. (2002). Fetal dose during radiotherapy: Clinical implementation and review of the literature. Cancer/Radiotherapie, 6(6), 352–357. doi:10.1016/S1278-3218(02)00249-4